Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ

0.75

-0.0372(-4.74%)

Updated at December 27 10:03AM

Currency In USD

Valuation

Market Cap338.33M
Enterprise Value421.93M
P/E Ratio-1.27
PEG Ratio-0.33
Price/Sales Ratio52.03
Price/Book Ratio1.52
Enterprise/Revenue64.77
Enterprise/EBITDA-1.69

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-41.09
Operating Margin-40.37

Management Effectiveness

Return On Assets-0.67
Return On Equity-1.07

Income Statement

Revenue1.2M
Revenue/Share0.01
Gross Profit1.12M
EBITDA-163.46M
Net Income-177.12M
Diluted EPS-0.8

Balance Sheet

Total Cash258.37M
Total Cash/Share0.71
Total Debt101.2M
Total Debt/Equity0.56
Current Ratio7.45
Book Value Per Share0.49

Price History

52-Week Change-48.79
52-Week High3.73
52-Week Low0.62
Moving Average 50 Days1.14
Moving Average 200 Days1.65

Statistics

Average Volume4.21M
Shares Outstanding361.49M
% Held by Institutions79.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:7
Last Split DateMay 21, 2015